QUIREDEX: Revlimid (Lenalidomide) and Dexamethasone (ReDex) Treatment Versus Observation in Patients With Smoldering Multiple Myeloma With High Risk of Progression

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

July 31, 2013

Conditions
Multiple Myeloma
Interventions
PROCEDURE

Maintenance with lower doses of lenalidomide and dexamethasone

After 9 cycles of lenalidomide and dexamethasone, it follows with lower doses for maintenance

Trial Locations (13)

Unknown

Hospital germans Trias i Pujol, Badalona

Hospital Clínic i Provincial de Barcelona, Barcelona

Hospital de la Santa Creu i Sant Pau, Barcelona

Hospital del SAS de Jerez de la Frontera, Jerez de la Frontera

Hospital de la Princesa, Madrid

Hospital Dode de Octubre, Madrid

Hospital Ramón y Cajal, Madrid

Hospital General Univeristario Morales Messeguer, Murcia

Hospital Clínico de Salamanca, Salamanca

Hospital Universitario de Canarias, Santa Cruz de Tenerife

Hospital Clínico de Valencia, Valencia

Hospital Universitario la Fe, Valencia

Hospital Clínico Universitario Lozano Blesa, Zaragoza

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Celgene Corporation

INDUSTRY

lead

PETHEMA Foundation

OTHER